N-3 Fatty acids prevent whereas trans-fatty acids induce vascular inflammation and sudden cardiac death

British Journal of Nutrition

Volumn 102, Issue 12, 2009, Pages 1811-1819

  Siddiqui, Rafat A ^a,b   Harvey, Kevin A ^a   Ruzmetov, Nargiz ^a,b   Miller, Steven J ^b   Zaloga, Gary P ^c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Inflammation; N 3 Fatty acids; Sudden cardiac death; Trans Fatty acids; Vascular remodelling

Indexed keywords

CELL PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TRANS FATTY ACID; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIETARY INTAKE; ENDOTHELIUM CELL; FEEDING; FEMORAL ARTERY; HEART INFARCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SUDDEN DEATH; SURVIVAL RATE; VASCULITIS; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CORONARY BLOOD VESSEL; DIET; DISEASE MODEL; DRUG EFFECT; LIGATION; PATHOLOGY; RAT; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; AORTA; ATHEROSCLEROSIS; CELL LINE; CORONARY VESSELS; DEATH, SUDDEN, CARDIAC; DIET; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMORAL ARTERY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIGATION; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; TRANS FATTY ACIDS; VASCULITIS;

EID: 74949132241     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509992030     Document Type: Article

References (52)

1. Siddiqui RA, Harvey KA & Zaloga GP (2008) Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J Nutr Biochem 19, 417-443.
2. Ascherio A, Hennekens CH, Buring JE, et al. (1994) Trans fatty acids intake and risk of myocardial infarction. Circulation, 89, 94-101.
3. Ascherio A (2002) Epidemiologic studies on dietary fats and coronary heart disease. Am J Med 113, Suppl. 9B, 9S-12S.
4. Harris WS (1996) n-3 Fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 31, 243-252.
5. Mori TA, Burke V, Puddey IB, et al. (2000) Purified eicosapen-taenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71, 1085-1094.
6. Abe Y, El-Masri B, Kimball KT, et al. (1998) Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 18, 723-731.
7. Harris WS, Ginsberg HN, Arunakul N, et al. (1997) Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 4, 385-391.
8. Mori TA, Beilin LJ, Burke V, et al. (1997) Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 17, 279-286.
9. Thies F, Garry JMC, Yaqoob P, et al. (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361, 477-485.
10. Geleijnse JM, Giltay EJ, Grobbee DE, et al. (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20, 1493-1499.
11. Mori TA (2006) Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol 33, 842-846.
12. De Caterina R, Liao JK & Libby P (2000) Fatty acid modulation of endothelial activation. Am J Clin Nutr 71, 213S-223S.
13. Chen W, Esselman WJ, Jump DB, et al. (2005) Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 46, 4342-4347.
14. Chen H, Li D, Chen J, et al. (2003) EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway. J Mol Cell Cardiol 35, 769-775.
15. Emken EA (1984) Nutrition and biochemistry of trans and positional fatty acid isomers in hydrogenated oils. Annu Rev Nutr 4, 339-376.
16. Lichtenstein AH, Ausman LM, Jalbert SM, et al. (1999) Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 340, 1933-1940
17. (see comment, erratum appears in N Engl J Med 1999 341, 856).
18. Kinsella JE, Bruckner G, Mai J, et al. (1981) Metabolism of trans fatty acids with emphasis on the effects of trans, trans-octadeca-dienoate on lipid composition, essential fatty acid, and prostaglan-dins: an overview. Am J Clin Nutr 34, 2307-2318.
19. Kummerow FA, Zhou Q, Mahfouz MM, et al. (2004) Trans fatty acids in hydrogenated fat inhibited the synthesis of the polyunsaturated fatty acids in the phospholipid of arterial cells. Life Sci 74, 2707-2723.
20. Mozaffarian D, Rimm EB, King IB, et al. (2004) Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 80, 1521-1525.
21. Lopez-Garcia E, Schulze MB, Meigs JB, et al. (2005) Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135, 562-566.
22. de Roos NM, Bots ML & Katan MB (2001) Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 21, 1233-1237.
23. Chin JP & Dart AM (1995) How do fish oils affect vascular function? Clin Exp Pharmacol Physiol 22, 71-81.
24. De Caterina R, Spiecker M, Solaini G, et al. (1999) The inhibition of endothelial activation by unsaturated fatty acids. Lipids 34 Suppl., S191-S194.
25. Dichtl W, Ares MPS, Jonson AN, et al. (2002) Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. Metabolism 51, 327-333.
26. Alvarez B, Ferrer-Sueta G, Freeman BA, et al. (1999) Kinetics of peroxynitrite reaction with amino acids and human serum albumin. J Biol Chem 274, 842-848.
27. Turko Mur IV & ad F (2002) Protein nitration in cardiovascular diseases. Pharmacol Rev 54, 619-634.
28. Zaloga GP, Ruzmetov N, Harvey KA, et al. (2006) (n-3) Long-chain polyunsaturated fatty acids prolong survival following myocardial infarction in rats. J Nutr 136, 1874-1878.
29. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447-455
30. (see comment, erratum appears in Lancet (2001) 357, 642).
31. Oomen CM, Ocke MC, Feskens EJ, et al. (2001) Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357, 746-751 (see comment).
32. Pietinen P, Ascherio A, Korhonen P, et al. (1997) Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Am J Epidemiol 145, 876-887.
33. Willett WC, Stampfer MJ, Manson JE, et al. (1993) Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341, 581-585, (see comment).
34. Mensink RP, Zock PL, Kester ADM, et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipopro-teins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146-1155.
35. Mensink RP & Katan MB (1990) Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 323, 439-445, (see comment).
36. Ascherio A, Katan MB, Zock PL, et al. (1999) Trans fatty acids and coronary heart disease. N Engl J Med 340, 1994-1998.
37. Lemaitre RN, King IB, Mozaffarian D, et al. (2006) Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation 114, 209-215.
38. Harvey KA, Arnold T, Rasool T, et al. (2008) Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 99, 723-731.
39. Moghadasian MH (2002) Experimental atherosclerosis: a historical overview. Life Sci 70, 855-865.
40. Masuda J & Ross R (1990) Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 10, 178-187.
41. Rosenfeld ME, Tsukada T, Gown AM, et al. (1987) Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 7, 9-23.
42. Scholz D, Cai WJ & Schaper W (2001) Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis 4, 247-257.
43. Gimbrone MA Jr (1993) Vascular Endothelial Dysfunction and the Pathogenesis of Atherosclerosis. New York: Raven Press.
44. Baylin A, Kabagambe EK, Ascherio A, et al. (2003) High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in costa rican adults. J Nutr 133, 1186-1191.
45. Erdei N, Toth A, Pasztor ET, et al. (2006) High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion. Am J Physiol Heart Circ Physiol 291, H2107-H2115.
46. Matsunaga T, Warltier DC, Weihrauch DW, et al. (2000) Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102, 3098-3103 (see comment).
47. Baffour R, Berman J, Garb JL, et al. (1992) Enhanced angio-genesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16, 181-191.
48. Grundmann S, Hoefer I, Ulusans S, et al. (2006) Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps. J Vasc Surg 43, 1263-1269.
49. Ito WD, Arras M, Winkler B, et al. (1997) Monocyte chemotac-tic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80, 829-837.
50. Seiler C, Pohl T, Wustmann K, et al. (2001) Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104, 2012-2017 (see comment).
51. Przybylski R (2007) Effect of food processing on trans fatty acids formation. 5th EuroFed Lipid Congress, 16-19 September, Gothenburg, Sweden, pp. 144.
52. Zambonin L, Prata C, Cabrini L, et al. (2008) Effect of radical stress and ageing on the occurrence of trans fatty acids in rats fed a trans free diet. Free Radic Biol Med 44, 591-601.